A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae

Current Hypertension Reports

Volumn 11, Issue 1, 2009, Pages 35-42

  Lynch, Amy I ^a   Claas, Steven A ^a   Arnett, Donna K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A;

AGE DISTRIBUTION; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; NONHUMAN; PROTEIN FUNCTION; REVIEW;

ATRIAL NATRIURETIC FACTOR; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC;

EID: 59149086957     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0008-7     Document Type: Review

References (46)

1. Nemer M, Chamberland M, Sirois D, et al.: Gene structure of human cardiac hormone precursor, pronatriodilatin. Nature 1984, 312: 654-656.
2. Ackermann U: Structure and function of atrial natriuretic peptides. Clin Chem 1986, 32: 241-247.
3. Chartier L, Schiffrin E, Thibault G: Effect of atrial natriuretic factor (ANF)-related peptides on aldosterone secretion by adrenal glomerulosa cells: Critical role of the intramolecular disulphide bond. Biochem Biophys Res Commun 1984, 122: 171-174.
4. Chartier L, Schiffrin E, Thibault G, et al.: Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo. Endocrinology 1984, 115: 2026-2028.
5. De Bold AJ: Heart atria granularity effects of changes in water-electrolyte balance. Proc Soc Exp Biol Med 1979, 161: 508-511.
6. De Bold AJ: Tissue fractionation studies on the relationship between an atrial natriuretic factor and specific atrial granules. Can J Physiol Pharmacol 1982, 60: 324-330.
7. Garcia R, Cantin M, Thibault G, et al.: Relationship of specific granules to the natriuretic and diuretic activity of rat atria. Experientia 1982, 38: 1071-1073.
8. John SW, Krege JH, Oliver PM, et al.: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995, 267: 679-681.
9. Steinhelper ME, Cochrane KL, Field LJ: Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 1990, 16: 301-307.
10. Barley J, Carter ND, Cruickshank JK, et al.: Renin and atrial natriuretic peptide restriction fragment length polymorphisms: association with ethnicity and blood pressure. J Hypertens 1991, 9: 993-996.
11. Beige J, Ringel J, Hohenbleicher H, et al.: HpaII-polymorphism of the atrial-natriuretic-peptide gene and essential hypertension in whites. Am J Hypertens 1997, 10: 1316-1318.
12. Berge KE, Berg K: No effect on blood pressure level or variability of polymorphisms in DNA at the locus for atrial natriuretic factor (ANF). Clin Genet 1994, 46: 433-435.
13. Cheung BM, Leung R, Shiu S, et al.: HpaII polymorphism in the atrial natriuretic peptide gene and hypertension. Am J Hypertens 1999, 12: 524-527.
14. Chiang FT, Tseng CD, Hsu KL, et al.: Atrial natriuretic peptide gene polymorphism is not associated with essential hypertension: Evidence of association with ethnic origin. J Hum Hypertens 1996, 10: 334.
15. Daniel HI, Munroe PB, Kamdar SM, et al.: The atrial natriuretic peptide gene and essential hypertension in African-Caribbeans from St Vincent and the Grenadines. J Hum Hypertens 1997, 11: 113-117.
16. Dedoussis GV, Maumus S, Skoumas J, et al.: Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia. J Clin Lab Anal 2006, 20: 98-104.
17. Frossard PM, Obineche EN, Lestringant GG, et al.: Association study between the ANF gene and hypertension in a Gulf Arab population. Am J Hypertens 1997, 10: 1308-1310.
18. Gruchala M, Ciecwierz D, Wasag B, et al.: Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 2003, 145: 125-131.
19. Hassan A, Ali N, Dong Y, et al.: Atrial natriuretic peptide gene G664A polymorphism and the risk of ischemic cerebrovascular disease. Neurology 2001, 57: 1726-1728.
20. Hu CJ, Wang CH, Lee JH, et al.: Association between polymorphisms of ACE, B2AR, ANP and ENOS and cardiovascular diseases: A community-based study in the Matsu area. Clin Chem Lab Med 2007, 45: 20-25.
21. Iemitsu M, Maeda S, Otsuki T, et al.: Arterial stiffness, physical activity, and atrial natriuretic Peptide gene polymorphism in older subjects. Hypertens Res 2008, 31: 767-774.
22. Kato N, Ikeda K, Nabika T, et al.: Evaluation of the atrial natriuretic peptide gene in stroke. Atherosclerosis 2002, 163: 279-286.
23. Kato N, Sugiyama T, Morita H, et al.: Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin Sci (Lond) 2000, 98: 251-258.
24. Lynch AI, Boerwinkle E, Davis BR, et al.: Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. Jama 2008, 299: 296-307.
25. Morris BJ, Zee RY, Ying LH, et al.: Independent, marked associations of alleles of the insulin receptor and dipeptidyl carboxypeptidase-I genes with essential hypertension. Clin Sci (Lond) 1993, 85: 189-195.
26. Nannipieri M, Manganiello M, Pezzatini A, et al.: Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension 2001, 37: 1416-1422.
27. Nkeh B, Tiago A, Candy GP, et al.: Association between an atrial natriuretic peptide gene polymorphism and normal blood pressure in subjects of African ancestry. Cardiovasc J S Afr 2002, 13: 97-101.
28. Ohta A, Sonoda A, Yatabe Y, et al.: [Study of genotype frequencies of ANP 664G/A polymorphism in normal subjects and CVD patients, and its association with plasma ANP levels]. Rinsho Byori 2002, 50: 296-300.
29. Rahmutula D, Nakayama T, Soma M, et al.: Association study between the variants of the human ANP gene and essential hypertension. Hypertens Res 2001, 24: 291-294.
30. Rubattu S, Bigatti G, Evangelista A, et al.: Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006, 48: 499-505.
31. Rubattu S, Evangelista A, Barbato D, et al.: Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans. J Hum Hypertens 2007, 21: 822-824.
32. Rubattu S, Ridker P, Stampfer MJ, et al.: The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 1999, 100: 1722-1726.
33. Rubattu S, Stanzione R, Di Angelantonio E, et al.: Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004, 35: 814-818.
34. Rutledge DR, Sun Y, Ross EA: Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 1995, 13: 953-955.
35. Schorr U, Beige J, Ringel J, et al.: Hpa II polymorphism of the atrial natriuretic peptide gene and the blood pressure response to salt intake in normotensive men. J Hypertens 1997, 15: 715-718.
36. Xue H, Wang S, Wang H, et al.: Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension. Clin Sci (Lond) 2008, 114: 131-137.
37. Zhang L, Cheng L, He M, et al.: ANP T2238C, C-664G gene polymorphism and coronary heart disease in Chinese population. J Huazhong Univ Sci Technolog Med Sci 2006, 26: 528-530.
38. Zorc-Pleskovic R, Bidovec M, Bregar D, et al.: The ScaI gene polymorphism of the atrial natriuretic factor and essential arterial hypertension in childhood. Coll Antropol 2004, 28: 617-621.
39. Ramasawmy R, Kotea N, Lu CY, et al.: Investigation of the polymorphic ScaI site by a PCR-based assay at the human atrial natriuretic peptides (hANP) gene locus. Hum Genet 1992, 90: 323-324.
40. Ramasawmy R, Kotea N, Lu C, et al.: A new polymorphic restriction site at the human atrial natriuretic peptide (hANP) gene locus. Hum Genet 1993, 91: 509-510.
41. Hollister AS, Inagami T: Atrial natriuretic factor and hypertension. A review and metaanalysis. Am J Hypertens 1991, 4(10 Pt 1): 850-865.
42. Rubattu S, SciarAetta S, Valenti V, et al.: Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008, 21: 733-741.
43. Vassalle C, Andreassi MG, Prontera C, et al.: Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP system on NP concentration in chronic heart failure. Clin Chem 2007, 53: 1886-1890.
44. Ciechanowicz A, Kurzawski G, Widecka K, et al.: [Mutation T-C of nucleotide 2238 in the gene of atrial natriuretic peptide (ANP) precursor and heterogeneity of sodium-sensitive hypertension. Preliminary report]. Pol Arch Med Wewn 1997, 98: 501-509.
45. Widecka K, Ciechanowicz A, Adler G, et al.: [Analysis of polymorphisms Sma (Hpa II) and Sca I gene precursors of atrial natriuretic peptide (ANP) in patients with essential hypertension]. Pol Arch Med Wewn 1998, 100: 27-34.
46. Montori VM, Amieja M, Guyatt GH: Publication bias: a brief review for clinicians. Mayo Clin Proc 2000, 75: 1284-1288.